Ilkka Kantola
 Professor; Head of Medical Division, Turku university Hospital

Docent,  Faculty of Medicine (University of Turku) ilkkan@utu.fi : https://orcid.org/0000-0002-6228-522X CURRICULUM VITAE OF ILKKA KANTOLA041117.pdf

  

  

  

9 of 10

  

  

  

---

• Both BMI and Waist Circumference Are Associated with Coronary Vasoreactivity in Overweight and Obese Men  (2012)  
  • Obesity Facts
   Sundell J, Raitakari OT, Viikari J, Kantola I, Nuutila P, Knuuti J

  
  

• Estimating glomerular filtration rate in hypertensive subjevts: comparison of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study equations  (2012)  
  • Annals of Medicine
   Korhonen Päivi, Kivelä Sirkka-Liisa, Aarnio Pertti, Kautiainen Hannu, Järvenpää Salme, Kantola Ilkka

  
  

• Fabryn tauti  (2012)  
  • Duodecim
   Ilkka Kantola, Maila Penttinen, Pirjo Nuutila, Jorma Viikari

  
  

• Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme  (2010)  
  • European Journal of Heart Failure
   Hawkins NM, Wang D, Petrie MC, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Solomon SD, Ostergren J, Michelson EL, Pocock SJ, Maggion AP, McMurray JJ, CHARM Investigators and Committees, Kantola I

  
  

• Cardiovascular events during differing hypertension therapies in patients with diabetes  (2010)  
  • Journal of the American College of Cardiology
   Weber MA, Bakris GL, Jamerson K, Weir M, Kjedsen SE, Devereux RB, Velazquez EJ, Dahlöf B, Kelly RY, Hua TA, Hester A, Pitt B, ACCOMPLISH Investigators, Kantola I

  
  

• Diabeetikon käsi- ja nivelmuutokset  (2010)  
  • Lääkärilehti
   Arkkila P, Viikari J, Kantola I

  
  

• Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke  (2010)  
  • Lancet Neurology
   Rothwell PM, Howard SC, Dolan E, O´Brien E, Dobson JE, Dahlöf B, Poulter NR, Sever PS, ASCOT-BPLA and MRC Trial Investigators, Kantola I

  
  

• Efficacy and safety of angiotensin receptor blockade are not mobified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity (CHARM) programme  (2010)  
  • European Journal of Heart Failure
   Chang SM, Cranger CB, Johansson PA, Kosolcharoen P, McMurray JJ, Michelson EL, Murray DR, Olofsson B, Pfeffer MA, Solomon SD, Swedberg K, Yusuf S, Dunlap ME, CHARM Investigators, Kantola I

  
  

• Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan; rampril; or both:(ONTARGET/TRANSCEND)Trials  (2010)  
  • Circulation
   Böhm M, Baumhäkel M, Teo K, Sleight P, Probstfield J, Gao P, Mann JF, Diaz R, Dagenais GR, Jennings GL, Liu L, Jansky P, Yusuf S, ONTARGET/TRANSCEND Erectile Dysfunction Substudy Investigators, Kantola I

  
  

• Evaluating enzyme replacement therapy in Fabry diease  (2010)  
  • Archives of Internal Medicine -New Series-
   Koskenvuo JW, Kantola IM